Biomechanical forces generated by blood ow play an important role in the pathogenesis of vascular disease. For example, regions exposed to non-uniform shear stresses develop early atherosclerotic lesions while areas exposed to uniform shear stresses are protected. A variety of in vitro ow apparatuses have been created to apply well-characterized ow patterns to endothelial cells in an effort to dissect the cellular and molecular pathways involved in these distinct processes. Recent advances in biotechnology have permitted large-scale transcriptional pro ling techniques to replace candidate gene screens and have allowed the genome-wide examination of biomechanical force-induced endothelial gene expression pro les. This review provides an overview of biomechanical force-induced modulation of endothelial phenotype. It examines the effect of sustained laminar shear stress (LSS), a type of uniform shear stress, on in vitro endothelial gene expression by synthesizing data from the early candidate gene and differential display polymerase chain reaction (PCR) approaches to the numerous, recent, high throughput functional genomic analyses. These studies demonstrate that prolonged LSS regulates the expression of only a small percentage ( 1¡5%) of endothelial genes, and this transcriptional pro le produces an endothelial phenotype that is quiescent, being protected from apoptosis, in ammation and oxidative stress. These observations provide a possible molecular mechanism for the strong correlation between patterns of blood ow and the occurrence of vascular pathologies, such as atherosclerosis, in vivo.
The endothelium, mechanical forces and vascular diseases
The endothelium is the cellular monolayer that lines the entire cardiovascular system. It is responsible for a variety of vital functions, such as vascular hemostasis, regulation of vascular tone and the maintenance of a selective permeability barrier. All of these endothelial functions can be modulated by both local and systemic environmental factors. F or example, systemic conditions such as bacteremia, diabetes mellitus and hyperlipidemia can activate the endothelial monolayer, resulting in the disruption of the selective permeability barrier, the establishment of a procoagulant surface, and the active recruitment of in ammatory leukocytes. At the same time, local stimuli, such as hemodynamic forces due to blood ow, can modify endothelial function leading to both short-term vasoactive responses and long-term remodelling of the vessel wall. This ability to sense its biochemical and biomechanical environment and modify its functional phenotype plays a de ning role in the maintenance of vascular homeostasis or the development of vascular pathology (F igure 1).
A variety of lines of evidence indicate that local and systemic uid mechanical forces contribute to vascular pathologies, such as atherosclerosis, in-stent restenosis and aneurysm formation. 1¡4 For example, the placement of venous conduit grafts into the arterial circulation during coronary artery bypass grafting leads to remodelling of these vessels that is dependent upon blood ow and wall shear stresses. 5, 6 A similar phenomenon is observed in the setting of arteriovenous stulae, where the increased ow plays a prominent role in the biological remodelling of the vessels involved. 7, 8 A number of groups have demonstrated that the magnitude of shear stress within stented regions of the coronary vasculature effects neointima formation and that by increasing the shear stress within the stented segment, both in ammation and neointimal hyperplasia can be reduced. 2, 9, 10 Meanwhile, the incidence and progression of abdominal aortic aneurysms is also signi cantly modulated by local and systemic hemodynamic environments, and alterations of these have been shown to favorably impact the progression of experimental aneurysms. 11 Of these pathologicial processes, the role of biomechanical forces in the development and progression of atherosclerosis is best characterized.
Two studies from approximately 20 years ago observed that non-uniform ow patterns contributed to early atherosclerosis while uniform ow patterns seemed to protect the vessel wall from disease. The rst of these studies examined the ow patterns and shear stresses in the carotid bifurcations of 12 adults with asymptomatic intimal plaques at autopsy. 12 This work demonstrated that intimal thickening and atherosclerotic changes developed at vascular bifurcations and that these regions were exposed to complex, non-uniform ow patterns consisting of low shear stresses, ow separation and non-laminar ow. Interestingly, the straight, tubular vascular segments, areas exposed to time-averaged unidirectional laminar ow of moderate to high shear stresses, did not develop these early lesions. F urther validation of this observation came from an autopsy study performed on American soldiers from the Korean War. 13 This analysis found that early atherosclerotic lesions in the coronary arteries were preferentially located at or near vessel bifurcations. G iven that the average age of these soldiers was 22.1 years, it was clear that there was more to the initiation of atherosclerotic lesions than merely traditional systemic cardiovascular risk factors. In their conclusions, the authors postulated that ow patterns dictated by coronary anatomy played a crucial role in the origin of atherosclerotic lesions. Although these studies elucidated the role of ow in the initiation of atherosclerosis, the cellular and molecular impact of distinct ow patterns on the endothelium and the vessel wall remained unclear.
Over the last quarter of a century, in vivo and in vitro analyses have focused on determining the etiology of the non-random localization of atherosclerotic lesions; as the sensor and transducer of distinct biomechanical forces, the endothelium has been a central area of investigation. These studies demonstrate that nonuniform, complex ow stimuli, such as disturbed or turbulent ows, result in the generation of reactive oxygen species (R OS) by endothelial cells followed by the expression of endothelial in ammatory markers, augmented endothelial cell turnover and increased endothelial cell loss=apoptosis. 14¡21 R egions of the vasculature exposed to time-averaged, uniform ow, such as laminar shear stress (LSS), demonstrate minimal cell turnover, low levels of apoptosis and an abundance of antioxidant and anti-in ammatory mediators. 12,19,22¡25 These disparate endothelial responses provide evidence for the role of ow in vascular disease and homeostasis.
The distinct phenotypic responses of the endothelium appear to result, in part, from alterations in gene expression and have led several groups to propose the 'atheroprotective gene hypothesis'. 19,22,26¡28 This hypothesis states that the uniform shear stresses associated with areas of the arterial vasculature that are typically 'resistant' to lesion formation, may selectively upregulate a subset of endothelial genes that can modulate the effects of systemic risk factors. Therefore, a comprehensive understanding of the adaptive phenotypic changes induced by uniform shear stresses at the level of the endothelial transcriptome may provide valuable insights into the pathogenesis, prevention and treatment of atherosclerosis.
Simplifying a complex process: ow models
In vivo intravascular hemodynamic forces are complex (F igure 2). They vary with cardiac cycle, heart rate, blood pressure, blood viscosity, vessel architecture and vascular viscoelastic properties. Biophysical ow models based on in vivo measurements and uid mechanical theory have provided insights into the types and magnitudes of ow that occur in different parts of the vasculature in vivo. To methodically examine the biological responses to these biomechanical forces, a variety of in vivo and in vitro experimental models have been developed ( Table 1 ).
In vivo ow models alter physiological blood ow by creating either an arti cial stenosis or a stula=graft ( Table 1) . One of the earliest in vivo models created a stenotic vascular segment in a region of previously laminar ow by tying suture material around the straight, tubular Figure 1 Effect of endothelial environment on vascular health and disease. Local and systemic environmental factors impact endothelial phenotype. These stimuli include biochemical substances, such as cytokines, growth factors and bacterial products, and biomechanical forces, such as cyclic strain and shear stress. The integrative response to these stimuli results in the alteration of endothelial structure and function that can lead to vascular health or disease.
Figure 2
In vivo biomechanical forces exerted on the endothelium. Endothelial cells which line the vessel wall are exposed to a variety of biomechanical forces generated by blood ow. This schematic diagram depicts the endothelial monolayer of the vessel wall in a longitudinal section. Shear stress is the tractive force per unit area in the direction of ow exerted by the viscous drag of blood on the endothelium. Due to the pulsatile nature of blood ow, the endothelium is exposed to cyclic stretching. As a container for blood, the endothelium is exposed to continuous pressure that uctuates between the systolic peak and diastolic trough.
V ascular M edicine 2004; 9: [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] portion of a vessel. 40 Regions proximal to and in the throat of the stenosis experienced time-averaged, uniform normal and high shear, respectively, while immediately distal to the stenosis, complex, non-uniform ow patterns that included ow separation, stagnation points, low laminar ow and eddy currents were observed. Morphometric analyses of these regions revealed that the endothelium exposed to time-averaged uniform shear stresses adopted a fusiform morphology with its longitudinal axis orientated in the direction of ow while the endothelium in the region of non-uniform ow patterns was cuboidal or 'cobblestone' in appearance. In addition to these morphologic changes, in vivo models have shown that the vessel wall exposed to nonuniform, complex ow patterns accumulates lipid and ultimately develops intimal hyperplasia while areas exposed to time-averaged, uniform shear in vivo are typically devoid of these early pathological changes. 41, 44, 45 In an effort to determine the impact of in vivo uid mechanical forces on the endothelium, in vitro models were created to expose endothelial cells to distinct biomechanical forces and de ne the molecular processes involved in endothelial adaptation to ow ( Table 1 ). The overall strength of the in vitro ow apparatuses was their ability to dissect out the effect of individual to complex biomechanical forces in a controlled, reproducible environment. Initial in vitro ow cuvette experiments exposing endothelial cells to sustained ( 24 h) physiological levels ( 10 dynes=cm 2 ) of LSS, a type of uniform ow, recapitulated the in vivo fusiform morphology. Interestingly, endothelial cells cultured under static, no-ow conditions had a morphologic appearance similar to cells exposed to nonuniform, disturbed ow patterns in vivo. This in vitro adoption of an in vivo-like endothelial morphology supported the use of in vitro ow models for the study of the endothelial response to ow.
To date, the majority of data describing the impact of uid mechanical forces on endothelial phenotype were derived from exposing cultured endothelial cells to prolonged LSS at a variety of magnitudes. The choice of LSS as the biomechanical stimulus re ects the robustness of the in vitro LSS models and the interest in identifying the molecular mechanisms involved in maintaining this in vivo 'protective' phenotype. Several early, seminal studies demonstrated that LSS applied to cultured endothelial cells were capable of inducing changes in gene expression. 46, 47 These, and subsequent studies, have resulted in the identi cation of a growing number of shear-responsive genes. 18,27,48¡59 . Interestingly, the in vitro endothelial expression of many of these shearregulated genes has been correlated to expression in the vascular endothelium in vivo.This suggests that these genes may play a signi cant role in endothelial biology in vivo. 48,51¡53,55,58 
Evaluating the transcriptional response to ow: technological progress
Early efforts to explore the process of LSS-induced endothelial gene expression in in vitro ow cuvettes utilized a variety of molecular approaches, such as candidate gene screening and differential display PCR. 52, 53, 60, 61 These studies resulted in the identi cation of a number of LSSresponsive genes, such as endothelin, tissue plasminogen activator (tPA), endothelial nitric oxide synthase (NOS3), TG F b1 and intercellular adhesion molecule 1 (ICAM 1), whose endothelial expression were con rmed in vivo. 46,51,58,62¡64 With the completion of the human genome project and advances in technology, it became possible to simultaneously evaluate the expression of tens of thousands of endothelial genes using a variety of transcriptional pro ling techniques. Emerging highthroughput technologies, such as microarrays and GeneCalling, were applied to identify endothelial genes that were responsive to biomechanical forces in vitro. 65¡70 These large-scale studies permitted a number of groups using different ow apparatuses, endothelial cell types and pro ling platforms, to characterize the molecular ngerprint of cultured endothelial cells exposed to uid mechanical forces, in particular LSS. The early and more recent gene expression data sets provide a large amount of information about endothelial adaptation to prolonged LSS. The synthesis of these data reveals potential molecular mechanisms for the 'athero-protected' endothelial phenotype in vivo.
The limited molecular response of the endothelium to ow
Based on conservative estimates, there are approximately 30 000¡40 000 genes in the human genome. About 15% of these species are expressed in a cell at any given time, which translates into the transcription of 4500¡6000 genes in the average cell. A transcriptional pro ling study by Garcia-Cardena et al, using a commercially available microarray that evaluated the expression of 11 397 genes in human endothelial cells, determined that approximately 21¡24% of the represented genes were detectable after 24 h of no ow, LSS or turbulent shear stress (TSS). 66 These disparate stimuli did not appear to drastically alter the total percentage of genes expressed. A closer examination of these data in conjunction with other transcriptional pro ling studies of cultured human endothelial cells exposed to distinct uid mechanical forces reveals that Table 1 Examples of common models of biomechanical forces. A variety of in vitro and in vivo systems have been engineered to apply distinct biomechanical forces to cultured cells or complex tissues. These model systems permit the examination of the effect of biomechanical forces on biological systems.
In vitro · cone-plate viscometer 29 · parallel-plate ow chamber 30¡32 · capillary-tube system 24, 33 · perfusion chamber 24 · pressurized chamber/system 34, 35 · uniaxial stretch 36 · Flexercell T M 37¡39 · distensible tube 24 In vivo · stenosis by extraluminal compression 40 · stenosis by intraluminal plug 41 · arteriovenous stula model 42 · polytetra uoroethylene graft 43
V ascular M edicine 2004; 9: [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] different ow patterns only alter the expression of a small number of genes. In vitro exposure of human endothelial cells to non-uniform ow patterns, such as disturbed ow (D F) and TSS, results in the regulation of 3¡8% and 0.8% of expressed genes, respectively. 66, 68 This suggests that a restricted set of genes may account for the dysfunctional, pathological phenotype of endothelial cells exposed to nonuniform, complex uid mechanical forces in vivo. Comparing the transcriptional pro les of endothelial cells exposed to prolonged steady LSS versus TSS (a non-laminar, non-uniform ow type), G arcia-Cardena et al found that the expression of only 100 genes (0.9%) differed signi cantly between the two ow regimes. 66 Based on this study, it appears that there is a set of endothelial genes that is regulated by both of these disparate biomechanical forces (i.e. responds to all types of ow) and there are separate sets of genes that respond to each of these distinct biomechanical forces (i.e. LSS or TSS). F urther functional analyses of these gene sets may provide insights into the drastically different phenotypes induced by these disparate ow patterns.
M uch effort has been placed on determining the endothelial gene expression pro le induced by sustained LSS (a uniform type of ow), given its putative role in inducing a 'protective' or athero-resistant endothelial phenotype in vivo. Genome-wide technologies, such as differential display PCR and GeneCalling, reveal that 2.6¡4% and 1.3% of the expressed genes are signi cantly regulated by 6 and 24 h, respectively, of LSS in human endothelial cells in vitro. 60, 69 Microarray platforms demonstrate that 24 h of LSS signi cantly regulates 1.3¡19.6% of the assayed genes in cultured human endothelial cells. 65¡68,70 Comparing microarray strategies, which evaluate the expression of a de ned set of genes, to genome-wide techniques, which distinguish differences in transcript levels among expressed genes, is problematic. Nevertheless, the percentage of endothelial genes modulated by LSS is relatively consistent despite the use of different in vitro ow cuvettes, culture conditions and sources of endothelial cells. It is also interesting that such a small percentage of the expressed genes ( < 4%) are regulated by sustained LSS, suggesting that a limited set of endothelial genes may be responsible for generating the 'athero-protective' phenotype associated with LSS.
Sustained LSS halts cell-cycle and cellular proliferation
Cellular growth is a complex process dependent on many overlapping pathways which require a variety of gene products that include cell-cycle components, soluble growth mediators, signaling molecules, transcription factors and the cellular machinery necessary for transcription and translation. The availability of many of these species is determined through transcriptional regulation. In vivo studies demonstrated that the majority of the vascular endothelium is quiescent, except for endothelial cells lining vascular curvatures and bifurcations. 71, 72 These in vivo observations have been replicated and extended in vitro, suggesting that local hemodynamic forces play an important role in regulating endothelial proliferation. 14,66,73¡75 At the molecular level, LSS upregulates growth inhibitory genes and downregulates genes essential for cell-cycle progression (F igures 3 and 4). Three cyclin-dependent kinase inhibitors, p21 Cip1=Waf1 , p57 Kip2 and Wee1, are upregulated by 24 h of LSS. 68, 75, 76 These proteins all inhibit cell-cycle progression. The proteins p21 Cip1=Waf1 and p57 Kip2 prevent G 1 to S phase transition while Wee1 halts the cell cycle at the G2 checkpoint (F igure 4). In addition, a number of genes with growth-inhibitory and tumorsuppressor activity, such as p53, pregnancy-induced growth inhibitor OKL38 and N -myc downstreamregulated gene (NDR G1), are upregulated by LSS. Interestingly, p53 upregulates p21 Cip1=Waf1 and G ADD 45 while downregulating cyclin B in endothelial cells, suggesting that this anti-proliferative gene program may be coordinated (F igure 4). 76, 77 F urthermore, the transcripts for p53 and p21 Cip1=Waf1 are upregulated by NOS3 as well as shear stress. Thus, this entire anti-proliferative cascade may be mediated by the shear-induction of NOS3 expression (F igure 4). 52, 78, 79 In addition to nitric oxide (NO) and its downstream effectors, the TGF b pathway may be an important component of the initiation and maintenance of endothelial quiescence (F igure 3). Shear-induced upregulation of soluble, active TGF b1 in endothelial cells in vitro and in vivo has been well-documented, and the role of TGF b1 in inhibiting proliferation and cell-cycle progression in many cell types, including endothelial cells, has been described. 58,80¡85 This antiproliferative effect of TG F b is dependent on the downregulation of the oncogene c-myc and the activation of cyclin-dependent kinase inhibitors like p21 Cip1=Waf1. 85, 86 Since endothelial expression of cmyc is not signi cantly affected by ow, p21 Cip1=Waf1 appears to be the primary mechanism for TG F b-mediated shear-induced growth arrest. 50, 75, 76, 87 A number of other genes involved in TGF b superfamily signaling, such as furin, Smads 6¡8, Ids 1¡3, endoglin, BMP4, BMP6 and serum=glucocorticoid regulated kinase (SGK ), are signicantly regulated by sustained LSS in cultured endothelial cells. 53, 58, 67, 69, 70, 88 Interestingly, many of these downstream transcriptional changes may be mediated through the ALK1 or ALK 5 receptors, type I TG Fb superfamily receptors expressed in the endothelium. 89, 90 The co-ordinated downregulation of genes necessary for cell-cycle progression and endothelial proliferation also appears to play an important role (F igure 3). These downregulated transcripts include components of the cell cycle, such as cyclin A, cyclin B, protein regulating cytokinesis 1 (PR C1) and Cdc2 (CD K1), and a number of kinases, such as polo-like kinase, deoxythymidylate kinase, and the protein tyrosine kinase SYK. 66,69,91¡94 The downregulation of these cell-cycle components by LSS suggests a potential mechanism for the shear-induced accumulation of endothelial cells in G 0 and G1. 66 F inally, there is a long list of growth-promoting genes that are downregulated by LSS (F igure 3); it includes a number of oncogenes such as R ET proto-oncogene, pituitary tumor transforming gene protein 1, and cytokines such as IL14, IL15 and placenta growth factor, as well as genes implicated in proliferation, such as cullin 3 and G 1 to S phase transition (GSPT1). 66,68,69,95¡97 Thus, the suppression of genes implicated in uncontrolled proliferation, and the enhanced expression of a repertoire of growth-inhibitory genes by 
Figure 4
Sustained laminar shear stress halts the cell cycle in endothelium. Transcriptional pro ling data from cultured human endothelial cells exposed to 24 h of LSS or no-ow conditions was employed to identify cell-cycle components that were signi cantly regulated by LSS in vitro. Genes that are upregulated by 24 h of LSS are displayed in bold type while LSS-downregulated genes are shown in italics. Prolonged LSS is a potent anti-proliferative stimulus; it upregulates genes that inhibit cell-cycle progression and downregulates genes whose products are required for cell-cycle progression.
V ascular M edicine 2004; 9: [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] LSS, provides a powerful molecular mechanism for the growth-inhibitory effects of this stimulus.
Prolonged LSS is an anti-apoptotic stimulus
Apoptosis has been described in regions of atherosclerotic plaque exposed to disturbed (non-laminar) ow patterns while the endothelium exposed to uniform (laminar) ow demonstrates remarkably low levels of apoptosis in vivo. 14,21,98¡101 In support of this, LSS is a potent antiapoptotic stimulus in endothelial cells in vitro. A potential molecular mechanism for this antiapoptotic phenotype is the profound upregulation of oxidoreductases by LSS in cultured endothelial cells. This family of genes includes copper-zinc superoxide dismutase (SOD 1), manganese superoxide dismutase (SOD 2), N OS3 and heme oxygenase 1 (HM OX1). The generation of N O by NOS3 suppresses endothelial apoptosis by abrogating caspase activity. 86,102¡104 The antioxidant proteins SOD1 and SOD 2 mediate their anti-apoptotic effect through similar caspase inhibition while H MOX1 prevents apoptosis by generating carbon monoxide. 56, 105, 106 Additional factors, such as iron and its reactive oxygen metabolites, play a role in initiating apoptosis. 107¡111 The observed shearinduced downregulation of the transferrin receptor and the upregulation of ferritin heavy and light chains may suppress oxidative stress-related endothelial apoptosis by scavenging iron radicals. 69, 70, 112, 113 TG F b and its signaling pathway appear to abrogate apoptosis as well. TGF b1, Smad6, Smad8 and the immediate early gene SG K are signi cantly upregulated by LSS, and are known to inhibit apoptosis in some contexts while the potentially proapoptotic growth factor BMP4 is downregulated by LSS in vitro. 65,67,69,114¡120 Lastly, a number of other antiapoptotic genes, such as GADD34 and clusterin, are upregulated by LSS while genes with proapoptotic properties, like thrombospondin 1, F as (tumor necrosis factor receptor superfamily, member 6) and CASP8 and F ADD -like apoptosis regulator (CF LAR ) are downregulated. 57,66,69,100,101,121¡124 The co-ordinate activation of genes with antiapoptotic properties and repression of genes with proapoptotic characteristics creates an antiapoptotic endothelial phenotype in the setting of sustained LSS.
The mitigation of oxidant stress and in ammation by LSS
There is a growing body of evidence that atherosclerosis is, in part, a chronic in ammatory process. 125¡127 One key in ammatory stimulus thought to be involved in the initiation and progression of atherosclerosis is oxidative stress generated by blood ow or cardiovascular risk factors, such as diabetes mellitus, hypertension, smoking and hyperlipidemia. 20,128¡131 Within 15 min of applying steady LSS to endothelial cells cultured under static conditions, elevated levels of intracellular ROS are detected. This acute increase in ROS is likely due to the fact that the in vitro system is arti cial (i.e. the endothelium under normal circumstances does not acutely go from a no-ow to LSS environment). Nevertheless, this augmented oxidative stress diminishes over the course of hours, which temporally corresponds to a process requiring transcriptional activation and de novo protein synthesis. 20, 129 The observed decrease in R OS in the setting of prolonged LSS is thought to result from the expression of a diverse set of endothelial genes with antioxidant and, thus, antiin ammatory properties. Recent transcriptional pro ling experiments support this hypothesis. An extensive list of genes with antioxidant properties, including NAD (P)H :menadione oxidoreductase, HMOX1, SOD1, SOD 2, cyclo-oxygenase 2 (COX2), NOS3, thioredoxin reductase, glutathione peroxidase, glutathione-Stransferase, g-glutamyl cysteine synthase, microsomal epoxide hydrolase, ferritin (heavy and light chains), glucose-6-phosphate dehydrogenase, cytochrome P450 1A1 and cytochrome P450 1B1, are upregulated by prolonged LSS. 52, 66, 67, 69, 70, 109, 111, 113 ,132¡136 (F igure 3). Although it is unlikely that all of these gene products maintain this antioxidant phenotype, the overall breadth of this genetic response suggests that the endothelium is capable of mounting a potent antioxidant response. Interestingly, there is evidence to suggest that this robust antioxidant response is dependent on the type of biomechanical force confronting the endothelium; some genes that are upregulated by uniform ow are not induced by non-uniform ow patterns. For example, HMOX1 is upregulated by both LSS and oscillatory shear with ow reversal (i.e. nonuniform), while both SOD1 and SOD 2 are downregulated by non-uniform ow patterns, but are upregulated by LSS. 20, 68 This apparent diminution of the antioxidant transcriptional response in the setting of non-uniform ow may explain why oscillatory shear stress with ow reversal generates a more robust and sustained elevation in intracellular oxygen radicals compared with LSS in vitro. 20 The role of uid ow and in ammation has been welldescribed in terms of the differential regulation of adhesion molecules. 51,68,137¡142 The prototypical example is the regulation of VCAM-1 by ow. VCAM -1 is upregulated at regions of atherosclerosis in vivo and in endothelial cells exposed to disturbed ow or in ammatory cytokines in vitro. 68, 142, 143 In vitro sustained LSS downregulates its expression in murine endothelial cells and abrogates its upregulation in response to cytokines in human endothelial cells. 137, 138 By governing the recruitment of leukocytes and the subsequent in ammatory response, the regulation of expression of VCAM-1 by distinct uid mechanical forces is thought to be important in the pathogenesis of atherosclerosis.
In addition to adhesion molecules, the expression of soluble factors or signaling molecules with in ammatory properties is dictated by ow. Proin ammatory cytokines, such as MCP1, IL14, IL15, thymus-expressed chemokine (CCL25), are downregulated by sustained LSS while anti-in ammatory species, such as TGF b1 and IL1 receptor-like 1 (IL1RL1), are upregulated by LSS. 144, 145 In fact, the expression of IL1R L1 and TN F receptorassociated factor-3 (TRAF -3), two LSS-upregulated genes, has been implicated in the inhibition of Toll-like receptors (TLR4 and TLR1) and CD40, respectively, two signaling pathways implicated in in ammation and atherosclerosis. 59, 145 Endothelial differentiation induced by LSS: sculpting the phenotypic response It has been hypothesized that uid ow acts as a differentiative stimuli to modulate endothelial phenotype=function. This hypothesis can be viewed on two levels. First, endothelial cells cultured in a static uid mechanical environment may be in an undifferentiated=dedifferentiated state due to the lack of ow. Prolonged application of LSS in vitro is hypothesized to differentiate=redifferentiate cultured endothelial cells to an 'in vivo' phenotype. Secondly, it is thought that the 'athero-protective' phenotype observed at regions of physiological LSS in vivo may be due to LSS-mediated differentiation (i.e. phenotypic modulation) of the endothelium. As described above, in vitro LSS induces a co-ordinated response at the level of gene expression and the presence of LSS-upregulated genes and gene products has been con rmed in the endothelium in vivo. It appears that the modulation of endothelial gene expression by prolonged LSS facilitates the differentiation of the endothelium into a more in vivo-like and 'athero-resistant' phenotype.
LSS regulates many genes involved in differentiation and development (F igure 3). F rom the shear-responsive transcriptional pro ling data in endothelial cells, it appears that this differentiative program is orchestrated by several signaling pathways and transcription factors. In particular, the VEGF and TG F b pathways appear to play a prominent role in LSS-induced phenotypic modulation in vitro. LSS-upregulated components of the VEGF signaling cascade include VEG F R-2 (i.e. KD R=F lk-1) and Tie2 (F igure 3). 61,65,67 VEGF R -2 is the primary mediator of the VEGF response in endothelial cells and is rapidly phosphorylated upon exposure to LSS. 146 It is required for endothelial cell differentiation from angioblast precursors and has also been implicated in endothelial survival during physiological stress. 147¡149 Tie2 is an endothelial receptor tyrosine kinase required for preservation of endothelial integrity and number. 150, 151 The upregulation of these two genes by sustained LSS seems to promote the differentiation and maintainence of a 'healthy' endothelial phenotype. Interestingly, antagonistic ligands for Tie2, such as angiopoietin 2, or growth factors for other VEGF pathways (VEG F R-1; VEGF R-3), such as VEGF -C and placenta growth factor, are downregulated by LSS (F igure 3). These LSS-downregulated gene products have been associated with endothelial proliferation, in ammation and loss of integrity. 152¡155 In terms of the TGF b signalling pathway, regulated species include soluble ligands, cell-surface receptors, intracellular signalling molecules, transcription factors and downstream effectors (F igure 3). As detailed above, these TGF b-related molecules have been implicated in preventing apoptosis, proliferation and in ammation.
Surprisingly, the mRN As for a number of transcription factors with important roles in development, such as gut-enriched Kruppel-like factors (GK LF ), lung Kruppel-like zinc nger transcription factor (LKLF ), Hairy=enhancer-of-split related with YR PW motif 2 (HEY2) and G ATA-binding protein 2 (GATA2), are upregulated by sustained LSS in cultured endothelial cells. 67, 69, 70 The expression of these transcription factors may account for some of the phenotypic changes observed in endothelial cells under shear stress. F or example, the two Kruppel-like transcription factors GK LF and LKLF play roles in growth arrest and cellular quiescence, respectively. 156¡158 Their induction by LSS in vitro may contribute to the quiescent phenotype of the endothelium in vivo. HEY2 and EphB4 are LSS-upregulated genes necessary for arterial and venous differentiation, respectively. 159, 160 Their induction by LSS in vitro and their essential role in vessel development suggests that LSS does indeed act as a differentiative stimulus. Overall, LSS appears to regulate a series of genes in endothelium that are involved in development and cellular differentiation. The roles of these transcription factors and signaling pathways in the adaptation to ow remain to be elucidated; however, this phenomenology raises the possibility that the endothelium under ow is a differentiated phenotype that requires the tonic expression of 'pro-differentiative' genes, and that these species generate and maintain the protected endothelial phenotype.
Conclusions: in vivo implications
Utilizing various in vitro ow models, gene expression pro ling techniques and endothelial cell types, we have begun to elucidate the molecular processes involved in the determination of endothelial phenotype induced by ow. These transcriptional pro ling studies point towards the LSS-induced upregulation of genes with antiproliferative, anti-apoptotic, antioxidant and antiin ammatory properties and the LSS-mediated downregulation of genes with growth-and=or apoptosis-promoting oxidant and in ammatory properties. There is also evidence from these studies to suggest that uniform ow, in the form of LSS, promotes the endothelial upregulation of transcription factors and signalling pathways (i.e. VEGF , TGF b) implicated in vascular development and differentiation. Importantly, many of the genes upregulated by LSS in cultured endothelial cells have been shown to be expressed in the vascular endothelium in vivo, suggesting that these regulated genes play an important role in the endothelial biology in vivo. Thus, these regulated species provide plausible pathways for the generation of the in vivo athero-resistant endothelial phenotype observed in regions of the vasculature exposed to timeaveraged uniform shear stresses. F urthermore, these LSS-regulated genes may also have an impact on the biological remodelling of bypass grafts and arterio-venous stulae, the inhibition of in-stent restenosis or the natural history of abdominal aortic aneurysms.
The molecular and cellular mechanisms linking LSS to athero-protection, and possibly vasoprotection, provides a potential area for therapeutic development. These in vitro gene expression pro ling studies have identi ed a number of key molecular pathways that may be implicated in creating an anti-apoptotic, anti-proliferative, antioxidant =anti-in ammatory and pro-differentiative endothelial phenotype. Directed analyses of individual molecular cascades, in an attempt to recapitulate this gene expression ngerprint, may facilitate the discovery of novel thera-V ascular M edicine 2004; 9: [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] peutic targets that protect the vasculature and promote endothelial health and homeostasis. The future development of therapeutic strategies that preserve and=or restore endothelial health may have a profound impact on the natural history and treatment of vascular diseases, and signi cantly improve the lives of patients suffering from these diseases.
